Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 6 Weeks in Adult and Adolescent Subjects 12 Years of Age and Older With Perennial Allergic Rhinitis (PAR)
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with perennial allergic rhinitis (PAR).
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 6 Weeks in Adult and Adolescent Subjects 12 years of Age and Older with Perennial Allergic Rhinitis (PAR)
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
No
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
Baltimore, Maryland, United States
GSK Investigational Site
Wheaton, Maryland, United States
GSK Investigational Site
North Dartmouth, Massachusetts, United States
GSK Investigational Site
Minneapolis, Minnesota, United States
GSK Investigational Site
Canton, Ohio, United States
GSK Investigational Site
Providence, Rhode Island, United States
GSK Investigational Site
South Burlington, Vermont, United States
GSK Investigational Site
Camperdown, New South Wales, Australia
GSK Investigational Site
Kippa-Ring, Queensland, Australia
Start Date
February 7, 2006
Primary Completion Date
July 1, 2006
Completion Date
July 4, 2006
Last Updated
April 13, 2018
301
ACTUAL participants
FF
DRUG
Placebo
DRUG
Lead Sponsor
GlaxoSmithKline
NCT00779545
NCT00406783
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT00988247